Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care
- PMID: 21417752
- DOI: 10.1146/annurev-publhealth-031210-101211
Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care
Abstract
Mortality rates from coronary heart disease (CHD), which had risen during the twentieth century in many countries, started declining in some countries during the 1960s. Once initial skepticism about the validity of the observed trends dissipated, researchers attempted to generate explanations about the events that had transpired using a variety of techniques, including ecological examinations of the trends in risk factors for CHD and changes in management of CHD, multivariate risk equations, and increasingly sophisticated modeling techniques. Improvements in risk factors as well as changes in cardiac treatments have both contributed to the reductions in CHD mortality, although estimates of their contributions have varied among countries. Models suggest that additional large reductions in CHD mortality are feasible by either improving the distribution of risk factors in the population or raising the percentage of patients receiving evidence-based treatments.
Similar articles
-
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005.JAMA. 2010 May 12;303(18):1841-7. doi: 10.1001/jama.2010.580. JAMA. 2010. PMID: 20460623
-
Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.BMJ. 2005 Sep 17;331(7517):614. doi: 10.1136/bmj.38561.633345.8F. Epub 2005 Aug 17. BMJ. 2005. PMID: 16107431 Free PMC article.
-
The role of public health versus invasive coronary interventions in the decline of coronary heart disease mortality.Ann Epidemiol. 2021 Mar;55:91-97. doi: 10.1016/j.annepidem.2020.10.005. Epub 2020 Nov 2. Ann Epidemiol. 2021. PMID: 33152465
-
A systematic review and economic evaluation of statins for the prevention of coronary events.Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140. Health Technol Assess. 2007. PMID: 17408535 Review.
-
Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke.J Atheroscler Thromb. 2007 Dec;14(6):278-86. doi: 10.5551/jat.e529. Epub 2007 Dec 17. J Atheroscler Thromb. 2007. PMID: 18174657 Review.
Cited by
-
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia.Biomedicines. 2024 Mar 6;12(3):588. doi: 10.3390/biomedicines12030588. Biomedicines. 2024. PMID: 38540200 Free PMC article.
-
Proteomic Analysis and Sex-Specific Changes in Chronically Ischemic Swine Myocardium Treated with Sodium-Glucose Cotransporter-2 Inhibitor Canagliflozin.J Am Coll Surg. 2024 Jun 1;238(6):1045-1055. doi: 10.1097/XCS.0000000000001021. Epub 2024 Jan 30. J Am Coll Surg. 2024. PMID: 38288953
-
Managing high cardiovascular disease risk among adults in Argentina using a multicomponent strategy linking key aspects of care: A two-arm cluster-randomized clinical trial (PRIMECare) protocol.Contemp Clin Trials. 2023 Nov;134:107357. doi: 10.1016/j.cct.2023.107357. Epub 2023 Oct 17. Contemp Clin Trials. 2023. PMID: 37852532
-
Body Fat Distribution, Diabetes Mellitus, and Cardiovascular Disease: an Update.Curr Cardiol Rep. 2023 Nov;25(11):1555-1564. doi: 10.1007/s11886-023-01969-5. Epub 2023 Oct 4. Curr Cardiol Rep. 2023. PMID: 37792133 Review.
-
Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transitions across BRICS-Plus Countries.Nutrients. 2023 Aug 28;15(17):3757. doi: 10.3390/nu15173757. Nutrients. 2023. PMID: 37686788 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources